Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
176.93
-0.17 (-0.10%)
Jul 25, 2025, 4:00 PM - Market closed
CRL Revenue
Charles River Laboratories International had revenue of $984.17M in the quarter ending March 29, 2025, a decrease of -2.71%. This brings the company's revenue in the last twelve months to $4.02B, down -2.16% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.
Revenue (ttm)
$4.02B
Revenue Growth
-2.16%
P/S Ratio
2.25
Revenue / Employee
$200,129
Employees
20,100
Market Cap
8.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 4.05B | -79.42M | -1.92% |
| Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
| Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
| Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
| Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| Novartis AG | 55.19B |
| AstraZeneca | 54.98B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
CRL News
- 4 days ago - Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development - Business Wire
- 11 days ago - Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call - Business Wire
- 5 weeks ago - Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment - Business Wire
- 7 weeks ago - Charles River Laboratories to Present at William Blair and Jefferies Conferences - Business Wire
- 2 months ago - Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research - Business Wire
- 2 months ago - Charles River Laboratories to Present at Bank of America Health Care Conference - Business Wire
- 2 months ago - Activist Elliott reaches key agreement with Charles River. Here are three ways to create value - CNBC
- 2 months ago - S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments - Investopedia